Related Experiment Video

Updated: Apr 21, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

9.3K

Silencing of E6/E7 expression in cervical cancer stem-like cells

Wenyi Gu1, Nigel McMillan, Chengzhong Yu

  • 1Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Corner College and Cooper Roads (Building 75), Brisbane, St. Lucia, QLD, 4072, Australia.

Methods in Molecular Biology (Clifton, N.J.)
|October 29, 2014
PubMed

Insights

Targeting cancer stem cells (CSCs) is key to preventing tumor recurrence and metastasis. This study details a method to silence human papillomavirus (HPV) oncogenes in cervical CSCs, offering a specific therapeutic approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Cancer stem cells (CSCs) drive tumor recurrence and metastasis, major causes of cancer mortality.
  • Targeting CSCs is crucial for developing advanced and effective cancer therapies.
  • Specific silencing of oncogenes in CSCs offers a promising strategy to inhibit tumor growth and overcome drug resistance.

Purpose of the Study:

  • To describe a method for silencing human papillomavirus (HPV) oncogenes E6/E7.
  • To target these oncogenes specifically within human cervical CSCs.
  • To utilize HeLa cells as a model system for this approach.

Main Methods:

  • Developing a method for gene silencing.
  • Applying the method to human cervical CSCs.
  • Using HeLa cells as a model for experimental validation.

Main Results:

  • Demonstration of a method to silence HPV oncogenes E6/E7 in cervical CSCs.
  • Validation of the method using HeLa cells.
  • Potential for specific targeting of CSCs to inhibit tumor progression.

Conclusions:

  • Silencing HPV oncogenes in cervical CSCs is achievable.
  • This targeted approach holds potential for novel cancer therapies.
  • Further research can explore broader applications in CSC-targeted treatments.

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

3.7K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.2K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.6K